The FDA cleared an investigational new drug application for SZN-8141, a Wnt agonist and VEGF antagonist antibody designed to ...

Dublin, Oct. 01, 2024 (GLOBE NEWSWIRE) -- The "Diabetic Macular Edema Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market for ...

Dublin, Oct. 09, 2024 (GLOBE NEWSWIRE) -- The "Non-Infectious Macular Edema Treatment - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering. The global market ...

Even with good control of the underlying uveitis through systemic immunomodulatory therapy, uveitic macular edema often ...

Diabetic macular edema (DME) is an eye condition that can lead to vision loss in people with diabetes. It occurs as a result of diabetic retinopathy — damaged blood vessels in the eyes due to elevated ...

Diabetic macular edema treatment options include anti-vascular endothelial growth factor (anti-VEGF) injections and laser therapy, with patient-specific factors guiding the best approach. What are the ...

Susvimo is an FDA-approved eye implant for diabetic macular edema that can be refilled every six months instead of requiring monthly injections. Diabetic macular edema affects about 5% to 7% of people ...

The optic cup and macula of a 24-year-old female. Image is released to Wikimedia commons with patient consent. Imaged with a non-mydriatic fundus camera at Pacific University College of Optometry.

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

LONDON--(BUSINESS WIRE)--The global diabetic macular edema treatment market 2018-2022 is expected to post a CAGR of more than 1% during the forecast period, according to the latest market research ...

Alessandro Di Battista underwent surgery in Cuba to remove almost all of a brain tumor after swelling caused headaches.